Secondary cancers

This trial is looking at a drug called MK-5684 for people with prostate cancer that has spread to another part of the body and has started to grow again.

This study is looking at an immunotherapy treatment called V940 (mRNA-4157) with pembrolizumab to treat melanoma.

This trial is looking at MK-2870 by itself or in combination with other drugs for some cancers of the digestive system.

This trial is looking at different ways to improve treatment for Ewing’s sarcoma. It’s mainly looking at changes to chemotherapy and radiotherapy.

This trial is comparing a new drug called MK-2870 with standard chemotherapy for cancer that has spread into surrounding tissues or to another part of the body.

This trial is looking at a drug called UCB4594 by itself and in combination with other treatments for solid cancers that have spread (advanced cancer).

This trial is looking at MK-2870 on its own or with pembrolizumab for people with breast cancer.

This trial is looking at treating pancreatic cancer that has spread to another part of the body with gemcitabine, pembrolizumab and IMM-101.

This trial is looking at rilvegostomig on its own or with datopotamab deruxtecan for non small cell lung cancer.

This trial is looking at a targeted cancer drug called sacituzumab govitecan in combination with the immunotherapy drug pembrolizumab.